Amjad H. Talukder
- Oncology top 5%
- HER2/EGFR in Cancer Research 6
- CAR-T cell therapy research 5
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 5
- Cell Biology top 5%
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 9
- Glycosylation and Glycoproteins Research 6
- Genetics top 5%
- Estrogen and related hormone effects 7
-
- Immunotherapy and Immune Responses 10
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Rakesh KumarChristopher J. BarnesRatna K. VadlamudiRajesh R. SinghSuresh K. RayalaRui‐An WangAnupama E. GururajSeetharaman Balasenthil
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Amjad H. Talukder
43 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 93
- Oncology 648
- Immunology and Allergy 123
- Cell Biology 315
- Molecular Biology 1.3k
- Genetics 360
Countries citing papers authored by Amjad H. Talukder
This map shows the geographic impact of Amjad H. Talukder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amjad H. Talukder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amjad H. Talukder more than expected).
Fields of papers citing papers by Amjad H. Talukder
This network shows the impact of papers produced by Amjad H. Talukder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amjad H. Talukder. The network helps show where Amjad H. Talukder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amjad H. Talukder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2021 | 31 | |
| 3 | 2017 | 24 | |
| 4 | 2015 | 124 | |
| 5 | 2015 | 7 | |
| 6 | 2012 | 41 | |
| 7 | 2008 | 10 | |
| 8 | 2008 | 21 | |
| 9 | 2007 | 12 | |
| 10 | 2007 | 74 | |
| 11 | 2007 | 61 | |
| 12 | 2006 | 53 | |
| 13 | 2004 | 45 | |
| 14 | Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors. | 2002 | 18 |
| 15 | 2002 | 198 | |
| 16 | 2001 | 26 | |
| 17 | 1999 | 60 | |
| 18 | 1998 | 32 | |
| 19 | 1996 | 17 | |
| 20 | 1996 | 29 |
About Amjad H. Talukder
Amjad H. Talukder is a scholar working on Immunology and Allergy, Oncology and Immunology, having authored 44 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Histone Deacetylase Inhibitors Research (9 papers), Estrogen and related hormone effects (7 papers), Glycosylation and Glycoproteins Research (6 papers), HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (5 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Oncology (648 citations), Immunology and Allergy (123 citations) and Cell Biology (315 citations). Amjad H. Talukder has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Rakesh Kumar, Christopher J. Barnes, Ratna K. Vadlamudi, Rajesh R. Singh, Suresh K. Rayala, Rui‐An Wang, Anupama E. Gururaj, Seetharaman Balasenthil, Liana Adam and Rakesh Kumar. Their work appears in journals such as Cancer Research, Oncogene, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.